Cargando…

Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever

Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoler, Iris, Freytag, Judith, Orak, Banu, Unterwalder, Nadine, Henning, Stephan, Heim, Katrin, von Bernuth, Horst, Krüger, Renate, Winkler, Stefan, Eschenhagen, Patience, Seipelt, Eva, Mall, Marcus A., Foell, Dirk, Kessel, Christoph, Wittkowski, Helmut, Kallinich, Tilmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325897/
https://www.ncbi.nlm.nih.gov/pubmed/32655537
http://dx.doi.org/10.3389/fimmu.2020.00716
_version_ 1783552228618928128
author Stoler, Iris
Freytag, Judith
Orak, Banu
Unterwalder, Nadine
Henning, Stephan
Heim, Katrin
von Bernuth, Horst
Krüger, Renate
Winkler, Stefan
Eschenhagen, Patience
Seipelt, Eva
Mall, Marcus A.
Foell, Dirk
Kessel, Christoph
Wittkowski, Helmut
Kallinich, Tilmann
author_facet Stoler, Iris
Freytag, Judith
Orak, Banu
Unterwalder, Nadine
Henning, Stephan
Heim, Katrin
von Bernuth, Horst
Krüger, Renate
Winkler, Stefan
Eschenhagen, Patience
Seipelt, Eva
Mall, Marcus A.
Foell, Dirk
Kessel, Christoph
Wittkowski, Helmut
Kallinich, Tilmann
author_sort Stoler, Iris
collection PubMed
description Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiation and perpetuation of inflammatory processes in FMF, but little is known about the specific characteristics of these cells in FMF patients. To further characterize neutrophilic inflammatory responses in FMF and to delineate gene–dose effects on a cellular level, we analyzed cytokine production and activation levels of isolated neutrophils derived from patients and subjects with distinct MEFV genotypes, as well as healthy and disease controls. Serum levels of interleukin-18 (IL-18) (median 11,485 pg/ml), S100A12 (median 9,726 ng/ml), and caspase-1 (median 394 pg/ml) were significantly increased in patients with homozygous M694V mutations. Spontaneous release of S100A12, caspase-1, proteinase 3, and myeloperoxidase (MPO) was restricted to ex vivo cultured neutrophils derived from patients with two pathogenic MEFV mutations. IL-18 secretion was highest in patients with two mutations but also increased in neutrophils from healthy heterozygous MEFV mutation carriers, exhibiting an ex vivo gene–dose effect, which was formerly described by us in patients' serum. CD62L (l-selectin) was spontaneously shed from the surface of ex vivo cultured neutrophils [median of geometric mean fluorescence intensity (gMFI) after 5 h: 28.8% of the initial level]. While neutrophils derived from healthy heterozygous mutation carriers again showed a gene–dose effect (median gMFI: 67.1%), healthy and disease controls had significant lower shedding rates (median gMFI: 83.6 and 82.9%, respectively). Co-culture with colchicine and/or stimulation with adenosine triphosphate (ATP) and lipopolysaccharide (LPS) led to a significant increase in receptor shedding. Neutrophils were not prevented from spontaneous shedding by blocking IL-1 or the NLRP3 inflammasome. In summary, the data demonstrate that ex vivo cultured neutrophils derived from FMF patients display a unique phenotype with spontaneous release of high amounts of IL-18, S100A12, MPO, caspase-1, and proteinase 3 and spontaneous activation as demonstrated by the loss of CD62L. Neutrophilic activation seems to be independent from IL-1 activation and displays a gene–dose effect that may be responsible for genotype-dependent phenotypes.
format Online
Article
Text
id pubmed-7325897
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73258972020-07-09 Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever Stoler, Iris Freytag, Judith Orak, Banu Unterwalder, Nadine Henning, Stephan Heim, Katrin von Bernuth, Horst Krüger, Renate Winkler, Stefan Eschenhagen, Patience Seipelt, Eva Mall, Marcus A. Foell, Dirk Kessel, Christoph Wittkowski, Helmut Kallinich, Tilmann Front Immunol Immunology Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiation and perpetuation of inflammatory processes in FMF, but little is known about the specific characteristics of these cells in FMF patients. To further characterize neutrophilic inflammatory responses in FMF and to delineate gene–dose effects on a cellular level, we analyzed cytokine production and activation levels of isolated neutrophils derived from patients and subjects with distinct MEFV genotypes, as well as healthy and disease controls. Serum levels of interleukin-18 (IL-18) (median 11,485 pg/ml), S100A12 (median 9,726 ng/ml), and caspase-1 (median 394 pg/ml) were significantly increased in patients with homozygous M694V mutations. Spontaneous release of S100A12, caspase-1, proteinase 3, and myeloperoxidase (MPO) was restricted to ex vivo cultured neutrophils derived from patients with two pathogenic MEFV mutations. IL-18 secretion was highest in patients with two mutations but also increased in neutrophils from healthy heterozygous MEFV mutation carriers, exhibiting an ex vivo gene–dose effect, which was formerly described by us in patients' serum. CD62L (l-selectin) was spontaneously shed from the surface of ex vivo cultured neutrophils [median of geometric mean fluorescence intensity (gMFI) after 5 h: 28.8% of the initial level]. While neutrophils derived from healthy heterozygous mutation carriers again showed a gene–dose effect (median gMFI: 67.1%), healthy and disease controls had significant lower shedding rates (median gMFI: 83.6 and 82.9%, respectively). Co-culture with colchicine and/or stimulation with adenosine triphosphate (ATP) and lipopolysaccharide (LPS) led to a significant increase in receptor shedding. Neutrophils were not prevented from spontaneous shedding by blocking IL-1 or the NLRP3 inflammasome. In summary, the data demonstrate that ex vivo cultured neutrophils derived from FMF patients display a unique phenotype with spontaneous release of high amounts of IL-18, S100A12, MPO, caspase-1, and proteinase 3 and spontaneous activation as demonstrated by the loss of CD62L. Neutrophilic activation seems to be independent from IL-1 activation and displays a gene–dose effect that may be responsible for genotype-dependent phenotypes. Frontiers Media S.A. 2020-06-11 /pmc/articles/PMC7325897/ /pubmed/32655537 http://dx.doi.org/10.3389/fimmu.2020.00716 Text en Copyright © 2020 Stoler, Freytag, Orak, Unterwalder, Henning, Heim, von Bernuth, Krüger, Winkler, Eschenhagen, Seipelt, Mall, Foell, Kessel, Wittkowski and Kallinich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Stoler, Iris
Freytag, Judith
Orak, Banu
Unterwalder, Nadine
Henning, Stephan
Heim, Katrin
von Bernuth, Horst
Krüger, Renate
Winkler, Stefan
Eschenhagen, Patience
Seipelt, Eva
Mall, Marcus A.
Foell, Dirk
Kessel, Christoph
Wittkowski, Helmut
Kallinich, Tilmann
Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title_full Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title_fullStr Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title_full_unstemmed Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title_short Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
title_sort gene–dose effect of mefv gain-of-function mutations determines ex vivo neutrophil activation in familial mediterranean fever
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325897/
https://www.ncbi.nlm.nih.gov/pubmed/32655537
http://dx.doi.org/10.3389/fimmu.2020.00716
work_keys_str_mv AT stoleriris genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT freytagjudith genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT orakbanu genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT unterwaldernadine genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT henningstephan genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT heimkatrin genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT vonbernuthhorst genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT krugerrenate genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT winklerstefan genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT eschenhagenpatience genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT seipelteva genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT mallmarcusa genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT foelldirk genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT kesselchristoph genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT wittkowskihelmut genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever
AT kallinichtilmann genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever